Impact of perfusion method on perioperative red blood cell transfusions and new-onset postoperative atrial fibrillation in mitral valve surgery patients

Perfusion. 2023 Nov;38(8):1600-1608. doi: 10.1177/02676591221122351. Epub 2022 Aug 23.

Abstract

Introduction: Red blood cell (RBC) transfusions are common in cardiac surgery and reportedly associated with increased mortality and morbidity, including increased risk of postoperative new-onset atrial fibrillation (NOAF). The aim of this study was to compare minimal invasive extracorporeal circulation (MiECC) and conventional extracorporeal circulation (CECC) in terms of RBC transfusions and the incidence of NOAF in mitral valve surgery.

Methods: The study population consisted of 89 MiECC and 169 CECC patients undergoing mitral valve surgery as an isolated procedure (80.6% of the patients) or in combination with coronary artery bypass grafting (19.4% of patients). 79.4% of the patients were male and the mean age was 62.1 years.

Results: 30.0% of patients aged < 65 years and 48.1% of patients aged ≥ 65 years needed RBC transfusion. The overall need for RBC transfusions did not differ between the treatment groups. Among patients < 65 years of age transfusions of ≥ 3 units were less frequent in MiECC than in CECC patients (OR 0.31, 95% CI 0.10-0.98, p = 0.045). The overall incidence of NOAF was 41.8% with no significant difference between MiECC and CECC groups. Red blood cell transfusions were associated with an increased risk of NOAF in an unadjusted analysis but not after adjustment for age and sex (OR 1.25, 95% CI 0.64-2.43, p = 0.515).

Conclusions: In mitral valve surgery MiECC compared to CECC was associated with less need of RBC units and platelets, particularly in patients aged < 65 years. Use of RBC transfusions was associated with increased risk of NOAF significantly only in unadjusted analysis.

Keywords: cardiac surgery; cardiopulmonary bypass; conventional extracorporeal circulation; minimal invasive extracorporeal circulation; mitral valve surgery; new-onset atrial fibrillation; postoperative atrial fibrillation; red blood cell transfusion.

MeSH terms

  • Aged
  • Atrial Fibrillation* / etiology
  • Cardiac Surgical Procedures* / adverse effects
  • Erythrocyte Transfusion / adverse effects
  • Erythrocyte Transfusion / methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve / surgery
  • Perfusion / adverse effects
  • Treatment Outcome